Skip to main content
Top
Published in: Implementation Science 1/2010

Open Access 01-12-2010 | Research article

The GRADE approach for assessing new technologies as applied to apheresis devices in ulcerative colitis

Authors: Nora Ibargoyen-Roteta, Iñaki Gutiérrez-Ibarluzea, Rosa Rico-Iturrioz, Marta López-Argumedo, Eva Reviriego-Rodrigo, Jose Luis Cabriada-Nuño, Holger J Schünemann

Published in: Implementation Science | Issue 1/2010

Login to get access

Abstract

Background

In the last few years, a new non-pharmacological treatment, termed apheresis, has been developed to lessen the burden of ulcerative colitis (UC). Several methods can be used to establish treatment recommendations, but over the last decade an informal collaboration group of guideline developers, methodologists, and clinicians has developed a more sensible and transparent approach known as the Grading of Recommendations, Assessment, Development and Evaluation (GRADE). GRADE has mainly been used in clinical practice guidelines and systematic reviews. The aim of the present study is to describe the use of this approach in the development of recommendations for a new health technology, and to analyse the strengths, weaknesses, opportunities, and threats found when doing so.

Methods

A systematic review of the use of apheresis for UC treatment was performed in June 2004 and updated in May 2008. Two related clinical questions were selected, the outcomes of interest defined, and the quality of the evidence assessed. Finally, the overall quality of each question was taken into account to formulate recommendations following the GRADE approach. To evaluate this experience, a SWOT (strengths, weaknesses, opportunities and threats) analysis was performed to enable a comparison with our previous experience with the SIGN (Scottish Intercollegiate Guidelines Network) method.

Results

Application of the GRADE approach allowed recommendations to be formulated and the method to be clarified and made more explicit and transparent. Two weak recommendations were proposed to answer to the formulated questions. Some challenges, such as the limited number of studies found for the new technology and the difficulties encountered when searching for the results for the selected outcomes, none of which are specific to GRADE, were identified. GRADE was considered to be a more time-consuming method, although it has the advantage of taking into account patient values when defining and grading the relevant outcomes, thereby avoiding any influence from literature precedents, which could be considered to be a strength of this method.

Conclusions

The GRADE approach could be appropriate for making the recommendation development process for Health Technology Assessment (HTA) reports more explicit, especially with regard to new technologies.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hanai H, Watanabe F, Yamada M, Sato Y, Takeuchi K, Iida T, Tozawa K, Tanaka T, Maruyama Y, Matsushita I, Iwaoka Y, Kikuch K, Saniabadi AR: Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitis. Digestion. 2004, 70 (1): 36-44. 10.1159/000080079.CrossRefPubMed Hanai H, Watanabe F, Yamada M, Sato Y, Takeuchi K, Iida T, Tozawa K, Tanaka T, Maruyama Y, Matsushita I, Iwaoka Y, Kikuch K, Saniabadi AR: Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitis. Digestion. 2004, 70 (1): 36-44. 10.1159/000080079.CrossRefPubMed
2.
go back to reference Bresci G, Parisi G, Mazzoni A, Scatena F, Capria A: Treatment of patients with acute ulcerative colitis: conventional corticosteroid therapy (MP) versus granulocytapheresis (GMA): a pilot study. Dig Liver Dis. 2007, 39 (5): 430-434. 10.1016/j.dld.2007.01.001.CrossRefPubMed Bresci G, Parisi G, Mazzoni A, Scatena F, Capria A: Treatment of patients with acute ulcerative colitis: conventional corticosteroid therapy (MP) versus granulocytapheresis (GMA): a pilot study. Dig Liver Dis. 2007, 39 (5): 430-434. 10.1016/j.dld.2007.01.001.CrossRefPubMed
3.
go back to reference Hanai H, Watanabe F, Takeuchi K, Saniabadi A, Bjamasson I: Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: A prospective uncontrolled study. Clin Gastroenterol Hepatol. 2003, 1: 28-35. 10.1053/jcgh.2003.50005.CrossRefPubMed Hanai H, Watanabe F, Takeuchi K, Saniabadi A, Bjamasson I: Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: A prospective uncontrolled study. Clin Gastroenterol Hepatol. 2003, 1: 28-35. 10.1053/jcgh.2003.50005.CrossRefPubMed
4.
go back to reference Hanai H, Iida T, Watanabe F, Yamada M, Takeuchi K, Kikuyama M, Maruyama Y, Iwaoka Y, Hirayama K, Saniabadi AR: Intensive granulocyte and monocyte apheresis versus intravenous prednisolone in patients with severe ulcerative colitis: a multicentre randomised conrolled study [abstract]. Gut. 2006, 55 (Suppl 2): A1- Hanai H, Iida T, Watanabe F, Yamada M, Takeuchi K, Kikuyama M, Maruyama Y, Iwaoka Y, Hirayama K, Saniabadi AR: Intensive granulocyte and monocyte apheresis versus intravenous prednisolone in patients with severe ulcerative colitis: a multicentre randomised conrolled study [abstract]. Gut. 2006, 55 (Suppl 2): A1-
5.
go back to reference Nishioka C, Aoyama N, Maekawa S, Shirasaka D, Nakahara T, Tamura T, Fukagawa M, Umezu M, Abe T, Kasuga M: Leukocytapheresis therapy for steroid-naive patients with active ulcerative colitis: its clinical efficacy and adverse effects compared with those of conventional steroid therapy. J Gastroenterol Hepatol. 2005, 20 (10): 1567-1571. 10.1111/j.1440-1746.2005.03907.x.CrossRefPubMed Nishioka C, Aoyama N, Maekawa S, Shirasaka D, Nakahara T, Tamura T, Fukagawa M, Umezu M, Abe T, Kasuga M: Leukocytapheresis therapy for steroid-naive patients with active ulcerative colitis: its clinical efficacy and adverse effects compared with those of conventional steroid therapy. J Gastroenterol Hepatol. 2005, 20 (10): 1567-1571. 10.1111/j.1440-1746.2005.03907.x.CrossRefPubMed
6.
go back to reference Yamamoto T, Umegae S, Kitagawa T, Yasuda Y, Yamada Y, Takahashi D, Mukumoto M, Nishimura N, Yasue K, Matsumoto K: Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective pilot study. Aliment Pharmacol Ther. 2004, 20 (7): 783-792. 10.1111/j.1365-2036.2004.02189.x.CrossRefPubMed Yamamoto T, Umegae S, Kitagawa T, Yasuda Y, Yamada Y, Takahashi D, Mukumoto M, Nishimura N, Yasue K, Matsumoto K: Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective pilot study. Aliment Pharmacol Ther. 2004, 20 (7): 783-792. 10.1111/j.1365-2036.2004.02189.x.CrossRefPubMed
7.
go back to reference McCarthy DA, Rampton DS, Liu YC: Peripheral blood neutrophils in inflammatory bowel disease: morphological evidence of in vivo activation in active disease. Clin Exp Immunol. 1991, 86: 489-493.CrossRefPubMedPubMedCentral McCarthy DA, Rampton DS, Liu YC: Peripheral blood neutrophils in inflammatory bowel disease: morphological evidence of in vivo activation in active disease. Clin Exp Immunol. 1991, 86: 489-493.CrossRefPubMedPubMedCentral
8.
go back to reference Pineda AA: Developments in the apheresis procedure for the treatment of inflammatory bowel disease. Inflamm Bowel Dis. 2006, 12 (Suppl 1): S10-S14. 10.1097/01.MIB.0000195386.19268.b3.CrossRefPubMed Pineda AA: Developments in the apheresis procedure for the treatment of inflammatory bowel disease. Inflamm Bowel Dis. 2006, 12 (Suppl 1): S10-S14. 10.1097/01.MIB.0000195386.19268.b3.CrossRefPubMed
9.
go back to reference Sakuraba A, Sato T, Naganuma M, Morohoshi Y, Matsuoka K, Inoue N, Takaishi H, Ogata H, Iwao Y, Hibi T: A pilot open-labeled prospective randomized study between weekly and intensive treatment of granulocyte and monocyte adsorption apheresis for active ulcerative colitis. J Gastroenterol. 2008, 43: 51-56. 10.1007/s00535-007-2129-6.CrossRefPubMed Sakuraba A, Sato T, Naganuma M, Morohoshi Y, Matsuoka K, Inoue N, Takaishi H, Ogata H, Iwao Y, Hibi T: A pilot open-labeled prospective randomized study between weekly and intensive treatment of granulocyte and monocyte adsorption apheresis for active ulcerative colitis. J Gastroenterol. 2008, 43: 51-56. 10.1007/s00535-007-2129-6.CrossRefPubMed
10.
go back to reference Sawada K, Kusugami K, Suzuki Y, Bamba T, Munakata A, Hibi T, Shimoyama T: Leukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case-control study with sham apheresis as placebo treatment. Am J Gastroenterol. 2005, 100 (6): 1362-1369. 10.1111/j.1572-0241.2005.41089.x.CrossRefPubMed Sawada K, Kusugami K, Suzuki Y, Bamba T, Munakata A, Hibi T, Shimoyama T: Leukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case-control study with sham apheresis as placebo treatment. Am J Gastroenterol. 2005, 100 (6): 1362-1369. 10.1111/j.1572-0241.2005.41089.x.CrossRefPubMed
11.
go back to reference Ibargoyen-Roteta N, Gutiérrez-Ibarluzea I, Cabriada-Nuño JL, Clofent-Vilaplana J, Ginard-Vicens D, Domènech-Morral E, Oliva-Oliva G, Queiro-Verdes T: Establecimiento de Estándares, registro y análisis de casos de tratamiento de la colitis ulcerosa mediante sistemas de aféresis. Informes de Evaluación de Tecnologías Sanitarias. 2006, Madrid: Plan Nacional para el SNS del MSC. Servicio de Evaluaciòn de Tecnologías Sanitarioas del País Vasco, OSTEBA N° 2006/5 Ibargoyen-Roteta N, Gutiérrez-Ibarluzea I, Cabriada-Nuño JL, Clofent-Vilaplana J, Ginard-Vicens D, Domènech-Morral E, Oliva-Oliva G, Queiro-Verdes T: Establecimiento de Estándares, registro y análisis de casos de tratamiento de la colitis ulcerosa mediante sistemas de aféresis. Informes de Evaluación de Tecnologías Sanitarias. 2006, Madrid: Plan Nacional para el SNS del MSC. Servicio de Evaluaciòn de Tecnologías Sanitarioas del País Vasco, OSTEBA N° 2006/5
12.
go back to reference Bianchi Porro G, Cassinotti A, Ferrara E, Maconi G, Ardizzone S: Review article: the management of steroid dependency in ulcerative colitis. Aliment Pharmacol Ther. 2007, 26: 779-794.CrossRefPubMed Bianchi Porro G, Cassinotti A, Ferrara E, Maconi G, Ardizzone S: Review article: the management of steroid dependency in ulcerative colitis. Aliment Pharmacol Ther. 2007, 26: 779-794.CrossRefPubMed
15.
go back to reference Atkins D, Eccles M, Flottorp S, Guyatt GH, Henry D, Hill S, Liberati A, O'Connell D, Oxman AD, Phillips B, Schünemann H, Edejer TT, Vist GE, Williams JW, The GRADE working group: Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group. BMC Health Serv Res. 2004, 4 (1): 38-10.1186/1472-6963-4-38.CrossRefPubMedPubMedCentral Atkins D, Eccles M, Flottorp S, Guyatt GH, Henry D, Hill S, Liberati A, O'Connell D, Oxman AD, Phillips B, Schünemann H, Edejer TT, Vist GE, Williams JW, The GRADE working group: Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group. BMC Health Serv Res. 2004, 4 (1): 38-10.1186/1472-6963-4-38.CrossRefPubMedPubMedCentral
16.
go back to reference Schünemann HJ, Best D, Vist G, Oxman AD: Letters, numbers symbols and words: how to communicate grades of evidence and recommendations. CMAJ. 2003, 169 (7): 677-680.PubMedPubMedCentral Schünemann HJ, Best D, Vist G, Oxman AD: Letters, numbers symbols and words: how to communicate grades of evidence and recommendations. CMAJ. 2003, 169 (7): 677-680.PubMedPubMedCentral
17.
go back to reference Schünemann HJ, Jaeschke R, Cook DJ, Bria WF, El-Solh AA, Ernst A, Fahy BF, Gould MK, Horan KL, Krishnan JA, Manthous CA, Maurer JR, McNicholas WT, Oxman AD, Rubenfeld G, Turino GM, Guyatt G, ATS Documents Development and Implementation Committee: An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med. 2006, 174 (5): 605-614. 10.1164/rccm.200602-197ST.CrossRefPubMed Schünemann HJ, Jaeschke R, Cook DJ, Bria WF, El-Solh AA, Ernst A, Fahy BF, Gould MK, Horan KL, Krishnan JA, Manthous CA, Maurer JR, McNicholas WT, Oxman AD, Rubenfeld G, Turino GM, Guyatt G, ATS Documents Development and Implementation Committee: An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med. 2006, 174 (5): 605-614. 10.1164/rccm.200602-197ST.CrossRefPubMed
18.
go back to reference Guyat GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, Schünemann HJ, GRADE Working Group: Going from evidence to recommendations. BMJ. 2008, 336 (7652): 1049-1051. 10.1136/bmj.39493.646875.AE.CrossRef Guyat GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, Schünemann HJ, GRADE Working Group: Going from evidence to recommendations. BMJ. 2008, 336 (7652): 1049-1051. 10.1136/bmj.39493.646875.AE.CrossRef
19.
go back to reference Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ, GRADE Working Group: GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008, 336 (7650): 924-926. 10.1136/bmj.39489.470347.AD.CrossRefPubMedPubMedCentral Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ, GRADE Working Group: GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008, 336 (7650): 924-926. 10.1136/bmj.39489.470347.AD.CrossRefPubMedPubMedCentral
20.
go back to reference Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schünemann HJ, for the GRADE Working Group: What is 'quality of evidence' and why is it important to clinicians?. BMJ. 2008, 336 (7651): 995-998. 10.1136/bmj.39490.551019.BE.CrossRefPubMedPubMedCentral Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schünemann HJ, for the GRADE Working Group: What is 'quality of evidence' and why is it important to clinicians?. BMJ. 2008, 336 (7651): 995-998. 10.1136/bmj.39490.551019.BE.CrossRefPubMedPubMedCentral
21.
go back to reference Schünemann HJ, Hill SR, Kakad M, Vist GE, Bellamy R, Stockman L, Wisløff TF, Del Mar C, Hayden F, Uyeki TM, Farrar J, Yazdanpanah Y, Zucker H, Beigel J, Chotpitayasunondh T, Hien TT, Ozbay B, Sugaya N, Oxman D: Transparent development of the WHO rapid advice guidelines. PLoS Med. 2007, 4 (5): e119-10.1371/journal.pmed.0040119.CrossRefPubMedPubMedCentral Schünemann HJ, Hill SR, Kakad M, Vist GE, Bellamy R, Stockman L, Wisløff TF, Del Mar C, Hayden F, Uyeki TM, Farrar J, Yazdanpanah Y, Zucker H, Beigel J, Chotpitayasunondh T, Hien TT, Ozbay B, Sugaya N, Oxman D: Transparent development of the WHO rapid advice guidelines. PLoS Med. 2007, 4 (5): e119-10.1371/journal.pmed.0040119.CrossRefPubMedPubMedCentral
22.
go back to reference Schünemann HJ, Oxman AD, Brozek J, Glasziou P, Jaeschke R, Vist GE, Williams JW, Kunz R, Craig J, Montori VM, Bossuyt P, Guyatt GH, GRADE Working Group: Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ. 2008, 336 (7653): 1106-1110. 10.1136/bmj.39500.677199.AE.CrossRefPubMedPubMedCentral Schünemann HJ, Oxman AD, Brozek J, Glasziou P, Jaeschke R, Vist GE, Williams JW, Kunz R, Craig J, Montori VM, Bossuyt P, Guyatt GH, GRADE Working Group: Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ. 2008, 336 (7653): 1106-1110. 10.1136/bmj.39500.677199.AE.CrossRefPubMedPubMedCentral
23.
go back to reference Cabriada-Nuño JL, Domènech E, Gomollón F, González-Carro P, González-Lara V, Hinojosa J, Jiménez-López CE, Nos P, Obrador A, Panès J, Saro C, Varea V, Lafuente R, Guilera M: Documento Consenso en el uso de la granulocitoaféresis en pacientes con enfermedad inflamatoria intestinal. Gastroenterol Hepatol. 2006, 29: 85-91. 10.1157/13083905.CrossRef Cabriada-Nuño JL, Domènech E, Gomollón F, González-Carro P, González-Lara V, Hinojosa J, Jiménez-López CE, Nos P, Obrador A, Panès J, Saro C, Varea V, Lafuente R, Guilera M: Documento Consenso en el uso de la granulocitoaféresis en pacientes con enfermedad inflamatoria intestinal. Gastroenterol Hepatol. 2006, 29: 85-91. 10.1157/13083905.CrossRef
25.
go back to reference Gutiérrez-Ibarluzea I, Arcelay A: Leucocitoaféresis para el tratamiento de la enfermedad inflamatoria intestinal. Informe de Revisión. Vitoria-Gasteiz. Departamento de Sanidad Gobierno Vasco. 2004, . Informe n° Osteba IR-04-03 Gutiérrez-Ibarluzea I, Arcelay A: Leucocitoaféresis para el tratamiento de la enfermedad inflamatoria intestinal. Informe de Revisión. Vitoria-Gasteiz. Departamento de Sanidad Gobierno Vasco. 2004, . Informe n° Osteba IR-04-03
26.
go back to reference GRADEpro: [Computer program]. Version 3.2 for Windows. 2008, Jan Brozek, Andrew Oxman, Holger Schünemann GRADEpro: [Computer program]. Version 3.2 for Windows. 2008, Jan Brozek, Andrew Oxman, Holger Schünemann
27.
go back to reference Sands BE, Sandborn WJ, Feagan B, Löfberg R, Hibi T, Wang T, Gustofson LM, Wong CJ, Vandervoort MK, Hanauer S, Adacolumn Study Group: A randomized double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis. Gastroenterology. 2008, 135 (2): 400-409. 10.1053/j.gastro.2008.04.023.CrossRefPubMed Sands BE, Sandborn WJ, Feagan B, Löfberg R, Hibi T, Wang T, Gustofson LM, Wong CJ, Vandervoort MK, Hanauer S, Adacolumn Study Group: A randomized double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis. Gastroenterology. 2008, 135 (2): 400-409. 10.1053/j.gastro.2008.04.023.CrossRefPubMed
28.
go back to reference D'Haens G, Sandborn WJ, Feagan BG, Geboes K, Hanauer SB, Irvine EJ, Lémann M, Marteau P, Rutgeerts P, Schölmerich J, Sutherland LR: A review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults with Ulcerative Colitis. Gastroenterology. 2007, 132 (2): 763-786. 10.1053/j.gastro.2006.12.038.CrossRefPubMed D'Haens G, Sandborn WJ, Feagan BG, Geboes K, Hanauer SB, Irvine EJ, Lémann M, Marteau P, Rutgeerts P, Schölmerich J, Sutherland LR: A review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults with Ulcerative Colitis. Gastroenterology. 2007, 132 (2): 763-786. 10.1053/j.gastro.2006.12.038.CrossRefPubMed
29.
go back to reference Sawada K, Muto T, Shimoyama T, Satomi M, Sawada T, Nagawa H, Hiwatashi N, Asakura H, Hibi T: Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column. Curr Pharm Des. 2003, 9 (4): 307-321. 10.2174/1381612033391928.CrossRefPubMed Sawada K, Muto T, Shimoyama T, Satomi M, Sawada T, Nagawa H, Hiwatashi N, Asakura H, Hibi T: Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column. Curr Pharm Des. 2003, 9 (4): 307-321. 10.2174/1381612033391928.CrossRefPubMed
30.
go back to reference Panés J, Guilera M, Ginard D, Hinojosa J, González-Carro P, González-Lara V, Varea V, Domènech E, Badia X: Treatment cost of ulcerative colitis is apheresis with Adacolumn cost-effective?. Dig Liver Dis. 2007, 39 (7): 617-625. 10.1016/j.dld.2007.03.007.CrossRefPubMed Panés J, Guilera M, Ginard D, Hinojosa J, González-Carro P, González-Lara V, Varea V, Domènech E, Badia X: Treatment cost of ulcerative colitis is apheresis with Adacolumn cost-effective?. Dig Liver Dis. 2007, 39 (7): 617-625. 10.1016/j.dld.2007.03.007.CrossRefPubMed
31.
go back to reference Jo Y, Matsumoto T, Mibu R, Iida M: Addition of leukocytapheress to steroid therapy: is it beneficial in recurrence of moderate-to severe ulcerative colitis?. Dis Colon Rectum. 2003, 46 (10 Suppl): S3-9.PubMed Jo Y, Matsumoto T, Mibu R, Iida M: Addition of leukocytapheress to steroid therapy: is it beneficial in recurrence of moderate-to severe ulcerative colitis?. Dis Colon Rectum. 2003, 46 (10 Suppl): S3-9.PubMed
32.
go back to reference Ricart E, Esteve M, Andreu M, Casellas F, Monfort D, Sans M, Oudovenko N, Lafuente R, Panes J: Evaluation of 5 versus 10 granulocytapheresis sessions in steroid-dependent ulcerative colitis: A pilot prospective, multicenter randomized study. World J Gatroenterol. 2007, 13 (15): 2193-2197.CrossRef Ricart E, Esteve M, Andreu M, Casellas F, Monfort D, Sans M, Oudovenko N, Lafuente R, Panes J: Evaluation of 5 versus 10 granulocytapheresis sessions in steroid-dependent ulcerative colitis: A pilot prospective, multicenter randomized study. World J Gatroenterol. 2007, 13 (15): 2193-2197.CrossRef
33.
go back to reference Cabriada-Nuño J, Bernal-Martínez A, Hernández-Martín A, Arévalo-Serna J, Fernández-Prado E: Aféresis leucocitaria en la inducción de la remisión y retirada de corticoides en la colitis ulcerosa corticodependiente. Dial Traspl. 2007, 28 (2): 47-55. Cabriada-Nuño J, Bernal-Martínez A, Hernández-Martín A, Arévalo-Serna J, Fernández-Prado E: Aféresis leucocitaria en la inducción de la remisión y retirada de corticoides en la colitis ulcerosa corticodependiente. Dial Traspl. 2007, 28 (2): 47-55.
34.
go back to reference Johnson FR, Özdemir S, Mansfield C, Mansfield C, Hass S, Miller DW, Siegel CA, Sands BE: Crohn's Disease Patients' Risk-Benefit Preferences: Serious Adverse Event Risks Versus Treatment Efficacy. Gastroenterology. 2007, 133 (3): 769-779. 10.1053/j.gastro.2007.04.075.CrossRefPubMed Johnson FR, Özdemir S, Mansfield C, Mansfield C, Hass S, Miller DW, Siegel CA, Sands BE: Crohn's Disease Patients' Risk-Benefit Preferences: Serious Adverse Event Risks Versus Treatment Efficacy. Gastroenterology. 2007, 133 (3): 769-779. 10.1053/j.gastro.2007.04.075.CrossRefPubMed
35.
go back to reference Atkins D, Briss PA, Eccles M, S Flottorp S, Guyatt GH, Harbour RT, Hill S, Jaeschke R, Liberati A, Magrini N, Mason J, O'Connell D, Oxman AD, Phillips B, Schünemann H, Edejer TT, Vist GE, Williams JW, The GRADE Working Group: Systems for grading the quality of evidence and the streght of recommendations II: Pilot study of a new system. BMC Health Serc Res. 2005, 5 (1): 25-10.1186/1472-6963-5-25.CrossRef Atkins D, Briss PA, Eccles M, S Flottorp S, Guyatt GH, Harbour RT, Hill S, Jaeschke R, Liberati A, Magrini N, Mason J, O'Connell D, Oxman AD, Phillips B, Schünemann H, Edejer TT, Vist GE, Williams JW, The GRADE Working Group: Systems for grading the quality of evidence and the streght of recommendations II: Pilot study of a new system. BMC Health Serc Res. 2005, 5 (1): 25-10.1186/1472-6963-5-25.CrossRef
36.
go back to reference Guyatt GH, Oxman AD, Kunz R, Jaeschke R, Helfand M, Liberati A, Vist GE, Schünemann HJ, for the GRADE working group: Incorporating considerations of resources use into grading recommendations. BMJ. 2008, 336 (7654): 1170-1173. 10.1136/bmj.39504.506319.80.CrossRefPubMedPubMedCentral Guyatt GH, Oxman AD, Kunz R, Jaeschke R, Helfand M, Liberati A, Vist GE, Schünemann HJ, for the GRADE working group: Incorporating considerations of resources use into grading recommendations. BMJ. 2008, 336 (7654): 1170-1173. 10.1136/bmj.39504.506319.80.CrossRefPubMedPubMedCentral
37.
go back to reference Calderón C, Rotaeche R, Etxebarria A, Marzo M, Rico R, Barandiaran M: Gaining insight into the Clinical Practice Guideline development processes: qualitative study in a workshop to implement the GRADE proposal in Spain. BMC Health Serv Res. 2006, 6: 138-10.1186/1472-6963-6-138.CrossRefPubMedPubMedCentral Calderón C, Rotaeche R, Etxebarria A, Marzo M, Rico R, Barandiaran M: Gaining insight into the Clinical Practice Guideline development processes: qualitative study in a workshop to implement the GRADE proposal in Spain. BMC Health Serv Res. 2006, 6: 138-10.1186/1472-6963-6-138.CrossRefPubMedPubMedCentral
38.
go back to reference Domènech E, Hinojosa J, Esteve-Comas M, Gomollón F, Herrera JM, Bastida G, Obrador A, Ruiz R, Saro C, Gassull MA, Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU): Granulocyte apheresis in steroid-dependent inflammatory bowel disease: a prospective open, pilot study. Aliment Pharmacol Ther. 2004, 20: 1347-1352. 10.1111/j.1365-2036.2004.02288.x.CrossRefPubMed Domènech E, Hinojosa J, Esteve-Comas M, Gomollón F, Herrera JM, Bastida G, Obrador A, Ruiz R, Saro C, Gassull MA, Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU): Granulocyte apheresis in steroid-dependent inflammatory bowel disease: a prospective open, pilot study. Aliment Pharmacol Ther. 2004, 20: 1347-1352. 10.1111/j.1365-2036.2004.02288.x.CrossRefPubMed
39.
go back to reference Muratov V, Lundahl J, Ulfgren AK, Elvin K, Fehrman I, Ahlborg N, Ost A, Hittel N, Saniabadi A, Löfberg R: Down-regulation of interferon-gamma parallels clinical response to selective leukocyte apheresis in patients with inflammatory bowel disease: a 12 month follow-up study. Int J Colorectal Dis. 2006, 21: 493-504. 10.1007/s00384-005-0069-2.CrossRefPubMed Muratov V, Lundahl J, Ulfgren AK, Elvin K, Fehrman I, Ahlborg N, Ost A, Hittel N, Saniabadi A, Löfberg R: Down-regulation of interferon-gamma parallels clinical response to selective leukocyte apheresis in patients with inflammatory bowel disease: a 12 month follow-up study. Int J Colorectal Dis. 2006, 21: 493-504. 10.1007/s00384-005-0069-2.CrossRefPubMed
41.
go back to reference Stange EF, Travis S, Vermeire S, Reinisch W, Geboes K, Barakauskiene A, Feakins R, Fléjou JF, Herfarth H, Hommes DW, Kupcinskas L, Lakatos PL, Mantzaris GJ, Schreiber S, Villanacci V, Warren BF, for the European Crohn's and Colitis Organisation (ECCO): European evidence-based Consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. JCC. 2008, 2: 1-23.PubMed Stange EF, Travis S, Vermeire S, Reinisch W, Geboes K, Barakauskiene A, Feakins R, Fléjou JF, Herfarth H, Hommes DW, Kupcinskas L, Lakatos PL, Mantzaris GJ, Schreiber S, Villanacci V, Warren BF, for the European Crohn's and Colitis Organisation (ECCO): European evidence-based Consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. JCC. 2008, 2: 1-23.PubMed
42.
go back to reference Abreu MT, Plevy S, Sands BE, Weinstein R: Selective Leukocyte Apheresis for the Treatment of Inflammatory Bowel disease. J Clin Gastroenterol. 2008, 41 (10): 874-888. 10.1097/MCG.0b013e3180479435.CrossRef Abreu MT, Plevy S, Sands BE, Weinstein R: Selective Leukocyte Apheresis for the Treatment of Inflammatory Bowel disease. J Clin Gastroenterol. 2008, 41 (10): 874-888. 10.1097/MCG.0b013e3180479435.CrossRef
Metadata
Title
The GRADE approach for assessing new technologies as applied to apheresis devices in ulcerative colitis
Authors
Nora Ibargoyen-Roteta
Iñaki Gutiérrez-Ibarluzea
Rosa Rico-Iturrioz
Marta López-Argumedo
Eva Reviriego-Rodrigo
Jose Luis Cabriada-Nuño
Holger J Schünemann
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Implementation Science / Issue 1/2010
Electronic ISSN: 1748-5908
DOI
https://doi.org/10.1186/1748-5908-5-48

Other articles of this Issue 1/2010

Implementation Science 1/2010 Go to the issue